Quick Answer
Arcutis Biotherapeutics, Inc. reported Shares Outstanding of 123.33 million shares for fiscal year 2025.
Arcutis Biotherapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 123.33M | +4.7% |
| 2024 | 117.85M | +21.8% |
| 2023 | 96.79M | +58.6% |
| 2022 | 61.04M | +21.5% |
| 2021 | 50.26M | +16.0% |
| 2020 | 43.34M | +1943.4% |
| 2019 | 2.12M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 120.29M | +2.8% | +0.4% |
| June 30, 2025 | 119.80M | +2.8% | +0.6% |
| March 31, 2025 | 119.14M | +3.1% | +1.1% |
| December 31, 2024 | 117.85M | +21.8% | +0.7% |
| September 30, 2024 | 117.00M | +89.1% | +0.4% |
| June 30, 2024 | 116.48M | +89.0% | +0.8% |
| March 31, 2024 | 115.51M | +88.2% | +19.3% |
| December 31, 2023 | 96.79M | +58.6% | +56.5% |
- Arcutis Biotherapeutics, Inc. showed an increase of +4.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Arcutis Biotherapeutics, Inc.’s shares outstanding has grown by 5715.2% (from 2.12 million shares to 123.33 million shares).
- The most recent figure is from Arcutis Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: